Sunitinib: — 4 Weeks On, 2 Weeks Off — and the 2/1 Option
Sunitinib is taken on a planned cycle, not every day without a break. Understanding when you take it and when you stop is the first thing most people want to know after collecting their prescription.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026
- One cycle is 42 days — 28 days of tablets, then 14 days off. That six-week block repeats for as long as the treatment is working.
- The break is part of the treatment — The 14 off-days are not a pause — they give your body time to recover before the next on-phase begins.
- A shorter cycle exists — The 2/1 schedule — 14 days on, 7 days off — is a recognised NCCN alternative, most often considered when side effects are hard to manage.
- Your oncologist decides — Both schedules use the same tablet dose. The choice depends on how you tolerate the drug and how it is working for you.
on Panel
Survival Rate*
Treated
(800+ reviews)
Sunitinib is taken once daily for 4 weeks, then stopped for 2 weeks — those 42 days are one cycle. A shorter option, 2 weeks on and 1 week off in a 21-day cycle, is also recognised by NCCN. Both use the same dose. Your oncologist chooses the schedule based on how you tolerate the drug.
How does the 4-weeks-on, 2-weeks-off schedule work?
You take one sunitinib tablet every day for 28 days. Then you take no tablets for 14 days. Those 42 days together are one cycle.
The two-week break is built into the treatment plan. It is not a sign that anything has gone wrong — the off-days give your body time to recover from the drug's effects before the next cycle begins.
Most people repeat this six-week cycle for as long as treatment is working and side effects stay manageable. Your oncologist reviews your blood results and symptoms before each new cycle starts.
What should you track through each cycle?
- Days 1–28: Take your tablet at the same time each day. Food is optional — pick whichever approach suits you and stay consistent.
- Days 29–42: No tablets, but keep reporting any new or worsening symptoms to your team — the break does not pause your monitoring.
- Attend blood test appointments during your off weeks. These results help decide whether your next cycle starts on schedule.
- Note which days your fatigue or side effects feel worst. Your team will ask this if a schedule change comes up.
- If you miss a dose, do not take two the next day. Let your team know at your next check-in.
- Before starting any new medicine, supplement or herbal preparation, tell your oncology team or pharmacist first.
What is the 2-weeks-on, 1-week-off schedule?
The 2/1 schedule means 14 days of tablets followed by 7 days off, repeated in a three-week cycle. The tablet dose stays the same as on the standard schedule.
It was developed because sunitinib's side effects tend to build up towards the end of the four-week on-phase. A shorter on-phase gives your body more frequent recovery time before those effects become severe.
NCCN includes the 2/1 schedule as a recognised alternative. Studies have compared it directly with the standard schedule, and your oncologist will weigh that evidence against your individual situation.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
When might your oncologist suggest switching to the 2/1 schedule?
A switch is most often considered when side effects in the final weeks of the on-phase are consistently difficult — severe fatigue, significant hand-foot syndrome, or nausea that has not settled before the next cycle starts.
The decision is individual. Your oncologist looks at your response to treatment, which side effects are most disruptive to daily life, and your overall fitness.
Switching schedules is not a sign that the treatment is failing. It is an adjustment to help you stay on therapy for as long as it is working.
What do these terms mean?
- Cycle
- One complete on-off sequence. On the 4/2 schedule, a cycle is 42 days. On the 2/1 schedule, it is 21 days.
- On-phase
- The days when you take the tablet. Sunitinib is active in your body throughout this period.
- Off-phase
- The days with no tablet. Side effects often ease during this time, though some effects carry into the first days of the break before fading.
- Dose reduction
- If side effects are significant, your oncologist may lower the daily tablet dose rather than change the schedule — or combine both adjustments.
- Hand-foot syndrome
- Redness, tenderness or peeling on the palms and soles. A common sunitinib effect that typically builds through the on-phase and eases during the break.
Did you know?
Sunitinib and its main active breakdown product have a long combined presence in the body — the drug keeps working for days after you take your last tablet of the cycle.
This is why some side effects carry into the first days of your break before they ease. The off-phase is doing something, even when it does not feel that way immediately.
Source: NCCN Clinical Practice Guidelines in Oncology: Kidney Cancer
Explore 75 more Kidney, Ovarian & Sarcoma Targeted Medicines topics
Drug Deep Dive: Sunitinib (Sutent)
- Diet and Nutrition While on Sunitinib
- Drug, Food and Supplement Interactions With Sunitinib
- Fertility, Pregnancy and Contraception on Sunitinib
- Hand-Foot Skin Reaction on Sunitinib: Prevention From Day One
- How Does Sunitinib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Sunitinib Take to Work?
- How Long Will You Stay on Sunitinib?
- Mouth Sores, Taste Loss and Yellow Skin Discolouration on Sunitinib
- Sunitinib (Sutent, Sunitix): The Complete Patient Guide
- Sunitinib After Kidney Surgery and for GIST: Two Different Settings
- Sunitinib Myths: Hair Colour Change, Dose Cuts and 'Weaker Treatment'
- Sunitinib Price in India: Brand, Generic and Monthly Cost
- Sunitinib Side Effects: The Complete List and Timeline
- Sunitinib Success Rate and Survival: An Honest Look at the Numbers
- Sunitinib and Immunotherapy: Where Combinations Fit in Kidney Cancer
- Sunitinib in Elderly Patients and Those With Other Illnesses
- Sunitinib vs Pazopanib vs Cabozantinib for Kidney Cancer
- Taking Sunitinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Sunitinib
- The 4-Weeks-On, 2-Weeks-Off Sunitinib Schedule and the 2/1 Alternative
- Thyroid Failure and Fatigue on Sunitinib: The Test to Repeat Every Cycle
- When Sunitinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Sunitinib? Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumours
- Will Insurance or a Government Scheme Pay for Sunitinib?
- Work, Travel and Daily Life on Sunitinib
Drug Deep Dive: Olaparib (Lynparza)
- Adjuvant Olaparib After Early Breast Cancer Surgery
- Anaemia and Extreme Fatigue on Olaparib
- Blood Cancer Risk After Long-Term Olaparib: How Real Is It?
- Diet and Nutrition While on Olaparib
- Drug, Food and Supplement Interactions With Olaparib
- Fertility, Pregnancy and Contraception on Olaparib
- How Does Olaparib Work? The PARP Inhibitor Explained
- How Long Does Olaparib Take to Work?
- How Long Will You Stay on Olaparib?
- Maintenance Olaparib: Taking a Drug When There Is No Visible Cancer
- Nausea on Olaparib: Managing the Most Common Side Effect
- Olaparib (Lynparza, Olanib): The Complete Patient Guide
- Olaparib Myths: 'Only for BRCA', 'It's Chemo', 'It Causes Cancer'
- Olaparib Price in India: Brand, Generic and Monthly Cost
- Olaparib Side Effects: The Complete List and Timeline
- Olaparib Success Rate and Survival: An Honest Look at the Numbers
- Olaparib With Bevacizumab or Hormone Therapy: Combination Regimens
- Olaparib in Elderly Patients and Those With Other Illnesses
- Olaparib vs Niraparib vs Talazoparib: Comparing PARP Inhibitors
- Taking Olaparib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Olaparib
- When Olaparib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Olaparib? BRCA-Mutated Ovarian, Breast, Prostate and Pancreatic Cancer
- Will Insurance or a Government Scheme Pay for Olaparib?
- Work, Travel and Daily Life on Olaparib
Drug Deep Dive: Pazopanib (Votrient)
- Diarrhoea and Blood Pressure Rise on Pazopanib
- Diet and Nutrition While on Pazopanib
- Drug, Food and Supplement Interactions With Pazopanib
- Fertility, Pregnancy and Contraception on Pazopanib
- Hair Turning White and Skin Lightening on Pazopanib
- How Does Pazopanib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Pazopanib Take to Work?
- How Long Will You Stay on Pazopanib?
- Liver Toxicity on Pazopanib: Why LFTs Are Checked Every Two Weeks
- Pazopanib (Votrient, Pazonib): The Complete Patient Guide
- Pazopanib Combinations: Why It Is Usually Given Alone
- Pazopanib Myths: Hair Colour, Liver Damage and Stopping Early
- Pazopanib Price in India: Brand, Generic and Monthly Cost
- Pazopanib Side Effects: The Complete List and Timeline
- Pazopanib Success Rate and Survival: An Honest Look at the Numbers
- Pazopanib for Soft Tissue Sarcoma: What It Can and Cannot Do
- Pazopanib in Elderly Patients and Those With Other Illnesses
- Pazopanib in Kidney Cancer vs Sarcoma: Two Different Treatment Goals
- Pazopanib vs Sunitinib: Comparing Toxicity and Quality of Life
- Taking Pazopanib on an Empty Stomach: Why the Timing Rule Exists
- Tests and Monitoring While You Are on Pazopanib
- When Pazopanib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Pazopanib? Kidney Cancer and Soft Tissue Sarcoma
- Will Insurance or a Government Scheme Pay for Pazopanib?
- Work, Travel and Daily Life on Pazopanib
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Frequently asked questions
Why 4 weeks on and 2 weeks off — why not take it every day?
Sunitinib affects normal tissue alongside cancer cells, and continuous daily use would not give your body the recovery time it needs. The off-phase is when many side effects settle and tolerance rebuilds before the next on-phase. The 4/2 schedule was established through clinical trials for this reason. The 2/1 schedule shortens both phases and was designed to spread that recovery more evenly across the month.
Can I take a longer break if I feel very tired?
Extending your break without guidance from your team is not recommended. The length of the off-phase is planned for clinical reasons, and taking extra time off on your own can affect how treatment works overall. If fatigue is severe enough that you feel you need more time, that is important information — tell your oncologist. There are planned ways to adjust the schedule or dose rather than improvising a longer break yourself.
Is the 2/1 schedule as effective as the standard schedule?
Studies comparing the two schedules have been published, and NCCN recognises both as options. We do not yet have enough long-term data to say definitively whether one is better than the other for all patients, which is why the decision is made individually. Your oncologist will weigh the available evidence against your specific situation rather than applying a single answer.
What happens if I accidentally take a tablet on an off day?
One extra tablet on an off day is unlikely to cause a serious problem, but tell your oncology team at your next contact. Do not try to compensate by skipping doses later. If you notice any unusual symptoms after the extra tablet, contact your team the same day. Keeping a simple calendar with on and off days marked is one of the most reliable ways to prevent this kind of error.
How many cycles of sunitinib will I need?
There is no fixed number decided in advance. Treatment continues for as long as it is working — meaning your cancer is responding or staying stable — and side effects remain manageable. Your oncologist assesses this at regular intervals using scans and blood tests. Some people are on sunitinib for many months; others need a change of treatment sooner. That decision is reviewed cycle by cycle based on your results.
Does the schedule change if the cancer stops responding?
If sunitinib stops controlling the cancer, changing the schedule does not change that outcome. Your oncologist will discuss moving to a different treatment rather than adjusting the timing. The schedule is modified for tolerability, not for response. If you are concerned that your cancer may not be responding, the right question to bring to your next appointment is about your scan results and whether a change of treatment is being planned.